CDK4 and gastric cancer: Dihydroartemisinin (DHA) exerts its anti-tumor activities through inhibition of CDK4 activity and targets Cyclin D1 negatively for induction of cell cycle arrest under in vivo and in vitro conditions in gastric cancer [90].